Global Label-Free Detection (Bio-layer interferometry, Optical waveguide grating technology, Surface Plasmon resonance) Market - Forecasts & Trends to 2018

DUBLIN, May 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/cj8mq4/labelfree) has announced the addition of the "Label-Free Detection Market - Global Forecasts & Trends to 2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The global label-free detection market is expected to grow at a CAGR of close to 11.86% between 2013 and 2018, to reach $1,708.23 million in 2018. Label-free detection is rapidly gaining widespread acceptance as a research and development tool in the pharmaceutical and biotech industry and academic research. It helps in the investigation of biomolecular interactions without auto-fluorescent, spatial-interference, or quenching effects of labels. The report provides a granular understanding of this market by identifying emergent technologies and changes in the user base and charting the product developments in this market. This report segments the global market by technology, application, product, end user, and geography.

The five technology segment of label-free detection market are bio-layer interferometry (BLI), cellular dielectric spectroscopy, optical waveguide grating technology (OWG), surface plasmon resonance (SPR) and other technology segments. The application segments are binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation, and other application segments. The product segments are instruments and consumables; while end user segments are academic research institutes, contract research organization, pharmaceutical and biotech companies and other end users.

Increasing drug discovery programs by pharmaceutical companies and academic institutes will drive the growth of this market along with the increasing molecular interaction analysis in drug discovery during the forecast period between 2013 and 2018. However, increasing market consolidation and high cost of instruments and consumables will restrain the growth of this market.

The global label-free detection market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at a faster rate during the forecast period due to increasing investments in drug discovery programs.

The major players in the label-free detection market are Ametek, Inc. (U.S.), Attana AB (Sweden), Bio-Rad Laboratories, Inc. (U.S.), BiOptix (U.S.), Corning, Inc. (U.S.), Danaher Corporation (U.S.), General Electric Corporation (U.S.), Pall Corporation (U.S.), PerkinElmer (U.S.), Roche (Switzerland), and X-BODY Bioscience (U.S.).

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Premium Insights

4 Market Overview

5 Global Label-Free Detection Market, By Technology

6 Global Label-Free Detection Market, By Application

7 Global Label-Free Detection Market, By Product

8 Global Label-Free Detection Market, By End User

9 Geographic Analysis

10 Competitive Landscape

11 Company Profiles

Companies Mentioned:

• Ametek, Inc.
• Attana Ab
• Bio-Rad Laboratories, Inc.
• Bioptix
• Corning, Inc.
• Danaher Corporation
• General Electric
• Pall Corporaion
• Perkinelmer, Inc.
• Roche Diagnostics
• X-Body Biosciences

For more information visit http://www.researchandmarkets.com/research/cj8mq4/labelfree

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net